Abstract
Most patients in the intensive care unit experience pain and anxiety, which are treated most commonly with an opioid or a benzodiazepine. These compounds are effective and have a well-established safety record. With the exception of associated respiratory depression, they have a relatively wide therapeutic window. New approaches and formulations for opioids and benzodiazepines are being used with continued success in the clinical setting.
Original language | English (US) |
---|---|
Pages (from-to) | 849-873 |
Number of pages | 25 |
Journal | Critical Care Clinics |
Volume | 11 |
Issue number | 4 |
DOIs | |
State | Published - 1995 |
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine